These genes include ATM (7.3% in IDC-P vs. 1% in all prostate cancers), FOXA1 (15% vs. 10%), and TP53 (19% vs. 10%) (Table 1) [34,35,36]. The gene discussed is FOXA1; the disease is prostate carcinoma.